These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11021517)

  • 1. Xenobiotic metabolism, genetic polymorphisms and male infertility.
    Schuppe HC; Wieneke P; Donat S; Fritsche E; Köhn FM; Abel J
    Andrologia; 2000 Sep; 32(4-5):255-62. PubMed ID: 11021517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic polymorphisms in xenobiotic metabolizing enzymes as a determinant of susceptibility to environmental mutagens and carcinogens in humans].
    Ozawa S
    Yakugaku Zasshi; 1997 Nov; 117(10-11):895-909. PubMed ID: 9414599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of genetic polymorphisms on population variability in six xenobiotic-metabolizing enzymes.
    Ginsberg G; Smolenski S; Neafsey P; Hattis D; Walker K; Guyton KZ; Johns DO; Sonawane B
    J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):307-33. PubMed ID: 20183525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of the xenobiotic-metabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus erythematosus.
    von Schmiedeberg S; Fritsche E; Rönnau AC; Specker C; Golka K; Richter-Hintz D; Schuppe HC; Lehmann P; Ruzicka T; Esser C; Abel J; Gleichmann E
    Adv Exp Med Biol; 1999; 455():147-52. PubMed ID: 10599336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic polymorphism of enzymes metabolizing xenobiotics as a factor in susceptibility to tumor development].
    Salagovic J; Kalina I; Dudas M
    Bratisl Lek Listy; 2000; 101(9):512-21. PubMed ID: 11187056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-environment interactions in esophageal cancer.
    Matejcic M; Iqbal Parker M
    Crit Rev Clin Lab Sci; 2015; 52(5):211-31. PubMed ID: 26220475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of the major polymorphic metabolizing enzymes.
    Daly AK
    Fundam Clin Pharmacol; 2003 Feb; 17(1):27-41. PubMed ID: 12588628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased frequencies of cytochrome P4501A1 polymorphisms in infertile men.
    Fritsche E; Schuppe HC; Döhr O; Ruzicka T; Gleichmann E; Abel J
    Andrologia; 1998; 30(3):125-8. PubMed ID: 9635090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variability in susceptibility and response to toxicants.
    Ingelman-Sundberg M
    Toxicol Lett; 2001 Mar; 120(1-3):259-68. PubMed ID: 11323184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphism of xenobiotic metabolising enzymes in Slovenian lung cancer patients.
    Dolzan V; Rudolf Z; Breskvar K
    Pflugers Arch; 2000; 439(3 Suppl):R29-30. PubMed ID: 10653131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment.
    Ginsberg G; Guyton K; Johns D; Schimek J; Angle K; Sonawane B
    Crit Rev Toxicol; 2010 Aug; 40(7):575-619. PubMed ID: 20662711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some aspects of interindividual variations in the metabolism of xenobiotics.
    Tamási V; Vereczkey L; Falus A; Monostory K
    Inflamm Res; 2003 Aug; 52(8):322-33. PubMed ID: 14504670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of individual susceptibility and DNA repair rate in workers exposed to xenobiotics in a tire plant.
    Vodicka P; Kumar R; Stetina R; Musak L; Soucek P; Haufroid V; Sasiadek M; Vodickova L; Naccarati A; Sedikova J; Sanyal S; Kuricova M; Brsiak V; Norppa H; Buchancova J; Hemminki K
    Environ Mol Mutagen; 2004; 44(4):283-92. PubMed ID: 15470755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the role of xenobiotic-metabolism in chemical carcinogenesis using gene knockout mice.
    Gonzalez FJ; Kimura S
    Mutat Res; 2001 Jun; 477(1-2):79-87. PubMed ID: 11376689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
    Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
    Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ sites for xenobiotic activation and detoxication: implications for the differential susceptibility of cells to the toxic actions of environmental chemicals.
    Baron J
    Prog Histochem Cytochem; 1991; 23(1-4):32-44. PubMed ID: 1947157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer.
    Kiyohara C
    J Epidemiol; 2000 Sep; 10(5):349-60. PubMed ID: 11059519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms and metabolism of endocrine disruptors in cancer susceptibility.
    Hatagima A
    Cad Saude Publica; 2002; 18(2):357-77. PubMed ID: 11923879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.
    Daly AK; Cholerton S; Armstrong M; Idle JR
    Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):55-61. PubMed ID: 7698086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.